Ravelcare Reports Robust H1 FY27 Results with PAT Doubling Sequentially
Ravelcare Ltd · Press Release · 14 Nov 2026, 1:32 am
Ravelcare Reports Robust H1 FY27 Results with PAT Doubling Sequentially Ravelcare Limited reported revenue from operations of ₹15.15 crore for H1 FY27, up 5.2% YoY and 20.7% against H2 FY26. PAT surged 19.8% YoY and 96.6% sequentially to ₹3.84 crore. EBITDA reached ₹4.48 crore with a margin of 29.6%, while gross margin expanded to 79.9%. The company remains debt-free with cash and investments of ₹26.6 crore as of 30th Sep'26. Growth was aided by launching the PRO range across quick commerce and e-commerce platforms, alongside plans for a personalized skincare launch in Dec'26.
Original exchange filing (PDF)
More announcements from Ravelcare Ltd
- Investor Presentation · 14 Nov 2026
- Statement of Deviation or Variation in Utilisation of Funds for the half year ended September 30, 2026. · 14 Nov 2026
- Financial Results for the half year ended September 30, 2026. · 14 Nov 2026
- Outcome of Board Meeting · 14 Nov 2026
- The Board Meeting is being postponed and rescheduled to be held on Friday, November 13, 2026 · 13 Nov 2026
- Ravelcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve the Unaudited Financial Results for .... · 12 Nov 2026
- Submission of Voting Results · 23 Sept 2026
- Proceedings of Annual General Meeting · 23 Sept 2026
